• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subclinical granulomas in benign skin lesions heralding the onset of and inhibitor-associated granulomatous dermatitis in a patient with metastatic melanoma.

作者信息

Korman Abraham M, Nisar Mahrukh S, Somach Stephen C

机构信息

Departments of Dermatology and Pathology, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.

出版信息

JAAD Case Rep. 2018 Aug 16;4(7):722-724. doi: 10.1016/j.jdcr.2018.05.011. eCollection 2018 Aug.

DOI:10.1016/j.jdcr.2018.05.011
PMID:30167445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6113653/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/a4951ae7d0e3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/cade935efa2b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/000af1bdf46e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/b3908b6631c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/a4951ae7d0e3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/cade935efa2b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/000af1bdf46e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/b3908b6631c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3824/6113653/a4951ae7d0e3/gr4.jpg

相似文献

1
Subclinical granulomas in benign skin lesions heralding the onset of and inhibitor-associated granulomatous dermatitis in a patient with metastatic melanoma.良性皮肤病变中的亚临床肉芽肿预示着一名转移性黑色素瘤患者发生α-1抗胰蛋白酶抑制剂相关肉芽肿性皮炎。
JAAD Case Rep. 2018 Aug 16;4(7):722-724. doi: 10.1016/j.jdcr.2018.05.011. eCollection 2018 Aug.
2
Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma.接受靶向 BRAF 抑制剂治疗转移性黑色素瘤的患者出现皮肤肉芽肿性皮疹，强效外用皮质类固醇治疗有效。
JAMA Dermatol. 2014 Mar;150(3):307-11. doi: 10.1001/jamadermatol.2013.7919.
3
Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases.联合 BRAF 和 MEK 抑制剂化疗的新型皮肤不良反应：两例报告。
Br J Dermatol. 2013 Jul;169(1):172-6. doi: 10.1111/bjd.12279.
4
Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report.考比替尼和维莫非尼诱发的肉芽肿性皮炎和硬红斑：一例报告。
SAGE Open Med Case Rep. 2019 May 16;7:2050313X19847358. doi: 10.1177/2050313X19847358. eCollection 2019.
5
BRAF Inhibitor-Associated Granulomatous Dermatitis: A Report of 3 Cases.BRAF抑制剂相关的肉芽肿性皮炎：3例报告
Am J Dermatopathol. 2019 Mar;41(3):214-217. doi: 10.1097/DAD.0000000000001276.
6
Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor.两例BRAF突变转移性黑色素瘤患者接受BRAF抑制剂和MEK抑制剂联合治疗时脂膜炎的临床观察
Eur J Dermatol. 2015 Apr;25(2):177-80. doi: 10.1684/ejd.2014.2512.
7
Sarcoidosis related to checkpoint and BRAF/MEK inhibitors in melanoma.黑色素瘤相关的检查点和 BRAF/MEK 抑制剂相关的结节病。
Autoimmun Rev. 2020 Aug;19(8):102587. doi: 10.1016/j.autrev.2020.102587. Epub 2020 Jun 14.
8
A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: a single-centre experience.晚期黑色素瘤患者中BRAF单药治疗与BRAF/MEK抑制剂联合治疗皮肤副作用的比较研究：单中心经验
Eur J Dermatol. 2017 Oct 1;27(5):482-486. doi: 10.1684/ejd.2017.3069.
9
MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors.MEK 抑制剂在转移性黑色素瘤和实体瘤治疗中的应用。
Am J Clin Dermatol. 2017 Dec;18(6):745-754. doi: 10.1007/s40257-017-0292-y.
10
Granulomatous Reactions from Tattoos Following BRAF Inhibitor Therapy.BRAF抑制剂治疗后纹身引起的肉芽肿反应。
Case Rep Dermatol. 2019 Apr 17;11(1):101-107. doi: 10.1159/000499959. eCollection 2019 Jan-Apr.

引用本文的文献

1
Mediastinal and hilar sarcoid-like reaction in a patient treated with dabrafenib and trametinib for metastatic melanoma: A case report and review of the literature.一名接受达拉非尼和曲美替尼治疗转移性黑色素瘤患者出现纵隔和肺门结节病样反应：病例报告及文献复习
Mol Clin Oncol. 2022 May;16(5):99. doi: 10.3892/mco.2022.2532. Epub 2022 Mar 18.
2
The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature.BRAF和MEK抑制剂治疗黑色素瘤患者的结节病样反应的诊断与管理。病例系列及文献综述。
Ther Adv Med Oncol. 2021 Oct 20;13:17588359211047349. doi: 10.1177/17588359211047349. eCollection 2021.

本文引用的文献

1
Cutaneous Side Effects of BRAF Inhibitors in Advanced Melanoma: Review of the Literature.BRAF抑制剂在晚期黑色素瘤中的皮肤副作用：文献综述
Dermatol Res Pract. 2016;2016:5361569. doi: 10.1155/2016/5361569. Epub 2016 Mar 3.
2
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy.BRAF和MEK抑制剂联合治疗黑色素瘤：最新证据及在治疗中的地位。
Ther Adv Med Oncol. 2016 Jan;8(1):48-56. doi: 10.1177/1758834015616934.
3
Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib.
一名BRAF V600E突变转移性黑色素瘤患者接受达拉非尼和曲美替尼治疗后出现肉芽肿性肾炎和皮炎。
Melanoma Res. 2015 Dec;25(6):550-4. doi: 10.1097/CMR.0000000000000186.
4
BRAF Inhibitor-Induced Antitumoral Granulomatous Dermatitis Eruption in Advanced Melanoma.BRAF抑制剂诱发的晚期黑色素瘤抗肿瘤性肉芽肿性皮炎皮疹
Am J Dermatopathol. 2015 Oct;37(10):795-8. doi: 10.1097/DAD.0000000000000281.
5
Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanoma.接受靶向 BRAF 抑制剂治疗转移性黑色素瘤的患者出现皮肤肉芽肿性皮疹，强效外用皮质类固醇治疗有效。
JAMA Dermatol. 2014 Mar;150(3):307-11. doi: 10.1001/jamadermatol.2013.7919.
6
Analysis of dermatologic events in vemurafenib-treated patients with melanoma.分析维莫非尼治疗黑色素瘤患者的皮肤事件。
Oncologist. 2013;18(3):314-22. doi: 10.1634/theoncologist.2012-0333. Epub 2013 Mar 1.
7
Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases.联合 BRAF 和 MEK 抑制剂化疗的新型皮肤不良反应：两例报告。
Br J Dermatol. 2013 Jul;169(1):172-6. doi: 10.1111/bjd.12279.
8
Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition.接受选择性 BRAF 抑制的晚期黑色素瘤患者中的非典型性黑素细胞增生和新原发性黑色素瘤。
J Clin Oncol. 2012 Jul 1;30(19):2375-83. doi: 10.1200/JCO.2011.41.1660. Epub 2012 May 21.